Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
28
-
Total 13F shares, excl. options
-
6.83M
-
Shares change
-
-99.1K
-
Total reported value, excl. options
-
$58.8M
-
Value change
-
-$772K
-
Number of buys
-
8
-
Number of sells
-
-14
-
Price
-
$8.61
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2018
33 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q1 2018.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.83M shares
of 71.9M outstanding shares and own 9.5% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.84M shares), RENAISSANCE TECHNOLOGIES LLC (2.64M shares), Neumann Advisory Hong Kong Ltd (403K shares), DEUTSCHE BANK AG\ (178K shares), Eqis Capital Management, Inc. (159K shares), STATE STREET CORP (136K shares), Invesco Ltd. (107K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (92.1K shares), Spark Investment Management LLC (66.1K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (46.7K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.